product summary
company name :
Hycult Biotech
product type :
antibody
product name :
Elafin, Human, mAb TRAB2F
catalog :
HM2063
quantity :
100 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
TRAB2F

The same clone is also sold as:
reactivity :
human
application :
western blot, immunohistochemistry - paraffin section
more info or order :
citations: 6
Reference
Marischen L, Wesch D, Schroder J, Wiedow O, Kabelitz D. Human gammadelta T cells produce the protease inhibitor and antimicrobial peptide elafin. Scand J Immunol. 2009;70:547-52 pubmed publisher
Caruso J, Hunt K, Keyomarsi K. The neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer. Cancer Res. 2010;70:7125-36 pubmed publisher
Yokota T, Bui T, Liu Y, Yi M, Hunt K, Keyomarsi K. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta. Cancer Res. 2007;67:11272-83 pubmed
Guedes Neto E, Edelweiss M, de Moraes G, Cristovam R, Savaris R. The influence of hydrosalpinx on endometrial elafin expression. Fertil Steril. 2011;95:2673-5 pubmed publisher
Drannik A, Nag K, Yao X, Henrick B, Jain S, Ball T, et al. Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells. J Virol. 2012;86:4599-610 pubmed publisher
Hunt K, Wingate H, Yokota T, Liu Y, Mills G, Zhang F, et al. Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Res. 2013;15:R3 pubmed
product information
Catalog no :
HM2063
Title :
Elafin, Human, mAb TRAB2F
Clone no :
TRAB2F
Quantity :
100 µg
Application code :
immunoassays,paraffin sections,western blot
Species :
human
Host species :
mouse
Isotype :
IgG2b
Conjugate :
purified
Aliases :
SKALP, ESI
Type :
mAb
Antigen :
Elafin
Meta data :
SKALP, ESI
more info or order :
company information
Hycult Biotech
Frontstraat 2a
5405 PB UDEN
support@hycultbiotech.com
www.hycultbiotech.com
31 0 413 25 13 35
headquarters: Netherlands
Hycult Biotech develops, produces and markets antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.

As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.